EUSA names new CEO
This article was originally published in Scrip
EUSA Pharma, a recently established specialty pharmaceutical company, has named Lee Morley CEO and Dr Göran Ando non-executive director. Mr Morley joins EUSA from Jazz Pharmaceuticals, where he was vice-president and head of commercial for Europe and international markets. At Jazz, Mr Morley had responsibility for the original EUSA Pharma business following its acquisition in 2012, until the recent launch of EUSA as a newly established independent company. He has also previously held a number of management positions in sales and marketing at Merck Sharp and Dohme.
You may also be interested in...
The Scrip 100 universe gathers FY 2019 financial performance data and compares the activities of the Top 100 biopharma businesses, ranked by pharma sales. Here In Vivo breaks out the Top 10 in the league table. Which big pharma holds the top spot this year?
Diversity in all forms is critical to innovation in health care, says AstraZeneca’s chief medical officer, Ann Taylor. In an exclusive interview, she talks about the company’s work in mentoring and education, and why tackling issues around diversity and inclusion must be driven by the C-suite alongside community initiatives.
A selection of articles you might have missed from October 2020, including exclusive interviews with industry leaders and a deeper dive into the Femtech market.